Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2012, Article ID 381929, 8 pages
http://dx.doi.org/10.1155/2012/381929
Clinical Study

Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases

1Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, P.O. Box 21, 00014 Helsinki, Finland
2Eastern Finland Laboratory Centre Joint Authority Enterprise (ISLAB), Mikkeli District Laboratory, Porrassalmenkatu 35-37, FI-50100 Mikkeli, Finland
3Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, P.O. Box 348, FI-00029 HUS, Helsinki, Finland
4Institute of Clinical Medicine, University of Helsinki, P.O. Box 20, 00014 Helsingin Yliopisto, Finland
5Department of Internal Diseases, Länsi-Uusimaa Hospital, P.O. Box 1020, Itäinen rantakatu 9, 10601 Tammisaari, Finland
6Department of Dermatology and Allergology, Helsinki University Central Hospital, P.O. Box 160, HUS 00029, Helsinki, Finland
7Division of Clinical Microbiology, Helsinki University Central Hospital, HUSLAB, P.O. Box 400, HUS 00029, Helsinki, Finland
8Division of Rheumatology, Department of Medicine, Helsinki University Central Hospital, P.O. Box 440, HUS 00029, Helsinki, Finland

Received 19 October 2011; Revised 6 March 2012; Accepted 13 March 2012

Academic Editor: Lazaros I. Sakkas

Copyright © 2012 Esko Tavast et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Winthrop and T. Chiller, “Preventing and treating biologic-associated opportunistic infections,” Nature Reviews. Rheumatology, vol. 5, no. 7, pp. 405–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. T. Giles and J. M. Bathon, “Serious infections associated with anticytokine therapies in the rheumatic diseases,” Journal of Intensive Care Medicine, vol. 19, no. 6, pp. 320–334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. B. Desai and D. E. Furst, “Problems encountered during anti-tumour necrosis factor therapy,” Best Practice and Research, vol. 20, no. 4, pp. 757–790, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Furst, J. Cush, S. Kaufmann, J. Siegel, and R. Kurth, “Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents,” Annals of the Rheumatic Diseases, vol. 61, no. 2, pp. ii62–ii63, 2002. View at Google Scholar · View at Scopus
  5. J. Ledingham and C. Deighton, “Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001),” Rheumatology, vol. 44, no. 2, pp. 157–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Solovic, M. Sester, J. J. Gomez-Reino et al., “The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement,” European Respiratory Journal, vol. 36, no. 5, pp. 1185–1206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Pai, A. Zwerling, and D. Menzies, “Systematic review: t-cell-based assays for the diagnosis of latent tuberculosis infection: an update,” Annals of Internal Medicine, vol. 149, no. 3, pp. 177–184, 2008. View at Google Scholar · View at Scopus
  8. E. Tavast, E. Salo, I. Seppälä, and T. Tuuminen, “IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland,” BMC Research Notes, vol. 2, article 9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tuuminen, E. Tavast, R. Väisänen, J. J. Himberg, and I. Seppälä, “Assessment of imprecision in gamma interferon release assays for the detection of exposure to mycobacterium tuberculosis,” Clinical and Vaccine Immunology, vol. 17, no. 4, pp. 596–601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kleinert, O. Kurzai, J. Elias et al., “Comparison of two interferon-γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases,” Annals of the Rheumatic Diseases, vol. 69, no. 4, pp. 782–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Soborg, M. Ruhwald, M. L. Hetland et al., “Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases,” Journal of Rheumatology, vol. 36, no. 9, pp. 1876–1884, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Laffitte, J. P. Janssens, P. Roux-Lombard et al., “Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test,” British Journal of Dermatology, vol. 161, no. 4, pp. 797–800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Matulis, P. Jüni, P. M. Villiger, and S. D. Gadola, “Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay,” Annals of the Rheumatic Diseases, vol. 67, no. 1, pp. 84–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Inanc, S. Z. Aydin, S. Karakurt, P. Atagunduz, S. Yavuz, and H. Direskeneli, “Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis,” Journal of Rheumatology, vol. 36, no. 12, pp. 2675–2681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. P. Jeong, Y. S. Ga, S. L. Jin, T. H. Kim, and D. H. Yoo, “Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial,” Journal of Rheumatology, vol. 36, no. 10, pp. 2158–2163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Martin, C. Walsh, A. Gibbs et al., “Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis,” Annals of the Rheumatic Diseases, vol. 69, pp. 181–185, 2010. View at Google Scholar
  17. T. Tuuminen, S. Sorva, K. Liippo et al., “Feasibility of commercial interferon-γ-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage,” Clinical Microbiology and Infection, vol. 13, no. 8, pp. 836–838, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Canada Communicable Disease Report, “Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection—2010 Update,” CCDR-RMTC, vol. 36, no. 5, 2010, http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10pdf/36-acs-5.pdf. View at Google Scholar
  19. Morbidity and Mortality Weekly Report, “Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States,” vol. 59, no. 5, 2010, http://www.cdc.gov/mmwr/pdf/rr/rr5905.pdf. View at Google Scholar
  20. R. L. Eisenberg and N. R. Pollock, “Low yield of chest radiography in a large tuberculosis screening program,” Radiology, vol. 256, no. 3, pp. 998–1004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. World Health Organization, “WHO Global tuberculosis control—epidemiology, strategy, financing,” 2010, http://www.who.int/tb/publications/global_report/2009/en/.
  22. P. Tapaninen, A. Korhonen, L. Pusa, I. Seppälä, and T. Tuuminen, “Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence?” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 3, pp. 347–355, 2010. View at Google Scholar · View at Scopus
  23. F. Bartalesi, S. Vicidomini, D. Goletti et al., “QuantiFERON-TB GOLD and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases,” European Respiratory Journal, vol. 33, pp. 586–593, 2009. View at Google Scholar